Citigroup
OMGA

Citigroup’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Citigroup’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,720
Closed -$2.03K – 6083
2024
Q4 		$2.03K Buy
2,720
+2,689
+8,674% +$2.68K ﹤0.01% 5545
2024
Q3 		$38 Sell
31
-9,541
-100% -$15.2K ﹤0.01% 5575
2024
Q2 		$19.8K Sell
9,572
-469,497
-98% -$1.11M ﹤0.01% 5002
2024
Q1 		$1.75M Buy
479,069
+366
+0.1% +$1.4K ﹤0.01% 2544
2023
Q4 		$1.44M Buy
478,703
+478,005
+68,482% +$969K ﹤0.01% 2528
2023
Q3 		$1.5K Sell
698
-49,211
-99% -$197K ﹤0.01% 5027
2023
Q2 		$279K Sell
49,909
-6,585
-12% -$51.5K ﹤0.01% 3718
2023
Q1 		$341K Buy
56,494
+22,950
+68% +$160K ﹤0.01% 3406
2022
Q4 		$192K Buy
33,544
+29,853
+809% +$168K ﹤0.01% 3742
2022
Q3 		$20K Buy
3,691
+2,729
+284% +$13.8K ﹤0.01% 4755
2022
Q2 		$4K Sell
962
-1,660
-63% -$6.18K ﹤0.01% 5726
2022
Q1 		$16K Sell
2,622
-759
-22% -$7.75K ﹤0.01% 5287
2021
Q4 		$38K Buy
3,381
+2,545
+304% +$48.4K ﹤0.01% 5198
2021
Q3 		$16K Buy
+836
New +$16K ﹤0.01% 5338

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Citigroup's OMGA Position: Q1 2025 in Review

Citigroup sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 2,720 shares — an estimated $2.03K sold.

Citigroup first reported a position in OMGA in Q3 2021 and held it in 14 quarters. The position peaked at $1.75M in Q1 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Citigroup reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Citigroup sold 2,720 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $2.03K.
  • Citigroup first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
  • Citigroup's Omega Therapeutics, Inc. Common Stock position peaked at $1.75M in Q1 2024.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.